California State Teachers Retirement System (CalSTRS)’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-63,898
| Closed | -$8.19M | – | 3052 |
|
|
2025
Q2 | $8.19M | Buy |
63,898
+5,310
| +9% | +$552K | 0.01% | 680 |
|
|
2025
Q1 | $5.19M | Sell |
58,588
-671
| -1% | -$65.5K | 0.01% | 854 |
|
|
2024
Q4 | $5.17M | Buy |
59,259
+2,742
| +5% | +$251K | 0.01% | 895 |
|
|
2024
Q3 | $5.23M | Sell |
56,517
-635
| -1% | -$63.1K | 0.01% | 897 |
|
|
2024
Q2 | $6.16M | Sell |
57,152
-919
| -2% | -$92K | 0.01% | 788 |
|
|
2024
Q1 | $5.51M | Sell |
58,071
-3,316
| -5% | -$284K | 0.01% | 871 |
|
|
2023
Q4 | $5.66M | Sell |
61,387
-5,503
| -8% | -$357K | 0.01% | 847 |
|
|
2023
Q3 | $3.36M | Sell |
66,890
-6,122
| -8% | -$327K | 0.01% | 1091 |
|
|
2023
Q2 | $4.61M | Sell |
73,012
-1,781
| -2% | -$96.8K | 0.01% | 1007 |
|
|
2023
Q1 | $3.36M | Sell |
74,793
-1,025
| -1% | -$46.2K | 0.01% | 1163 |
|
|
2022
Q4 | $3.32M | Buy |
75,818
+963
| +1% | +$46.2K | 0.01% | 1183 |
|
|
2022
Q3 | $4.93M | Sell |
74,855
-1,174
| -2% | -$75.4K | 0.01% | 914 |
|
|
2022
Q2 | $3.84M | Buy |
76,029
+3,196
| +4% | +$187K | 0.01% | 1097 |
|
|
2022
Q1 | $4.65M | Sell |
72,833
-6,145
| -8% | -$441K | 0.01% | 1097 |
|
|
2021
Q4 | $8.46M | Buy |
78,978
+1,953
| +3% | +$204K | 0.01% | 842 |
|
|
2021
Q3 | $7.92M | Sell |
77,025
-8,863
| -10% | -$825K | 0.01% | 922 |
|
|
2021
Q2 | $7.55M | Sell |
85,888
-2,804
| -3% | -$257K | 0.01% | 959 |
|
|
2021
Q1 | $8.62M | Sell |
88,692
-282
| -0.3% | -$28.2K | 0.01% | 874 |
|
|
2020
Q4 | $9.98M | Buy |
88,974
+86
| +0.1% | +$9.06K | 0.01% | 765 |
|
|
2020
Q3 | $8.24M | Buy |
88,888
+7,151
| +9% | +$551K | 0.01% | 759 |
|
|
2020
Q2 | $6.38M | Buy |
81,737
+360
| +0.4% | +$24.3K | 0.01% | 832 |
|
|
2020
Q1 | $4.76M | Buy |
81,377
+6,788
| +9% | +$437K | 0.01% | 844 |
|
|
2019
Q4 | $5.97M | Sell |
74,589
-1,507
| -2% | -$113K | 0.01% | 921 |
|
|
2019
Q3 | $5.59M | Buy |
76,096
+909
| +1% | +$78.6K | 0.01% | 927 |
|
|
2019
Q2 | $7.09M | Buy |
75,187
+11,877
| +19% | +$980K | 0.01% | 807 |
|
|
2019
Q1 | $5.07M | Sell |
63,310
-1,408
| -2% | -$104K | 0.01% | 961 |
|
|
2018
Q4 | $3.49M | Buy |
64,718
+1,459
| +2% | +$88.7K | 0.01% | 1116 |
|
|
2018
Q3 | $4.94M | Sell |
63,259
-22
| -0% | -$1.53K | 0.01% | 1029 |
|
|
2018
Q2 | $4.02M | Sell |
63,281
-1,495
| -2% | -$119K | 0.01% | 1153 |
|
|
2018
Q1 | $5.94M | Sell |
64,776
-2,271
| -3% | -$196K | 0.01% | 871 |
|
|
2017
Q4 | $5.06M | Buy |
67,047
+4,861
| +8% | +$342K | 0.01% | 992 |
|
|
2017
Q3 | $4.33M | Sell |
62,186
-6,675
| -10% | -$357K | 0.01% | 1075 |
|
|
2017
Q2 | $3.49M | Buy |
68,861
+20,999
| +44% | +$892K | 0.01% | 1252 |
|
|
2017
Q1 | $1.91M | Buy |
47,862
+6,600
| +16% | +$236K | ﹤0.01% | 1658 |
|
|
2016
Q4 | $1.16M | Sell |
41,262
-1,000
| -2% | -$30.1K | ﹤0.01% | 2018 |
|
|
2016
Q3 | $1.25M | Buy |
42,262
+300
| +0.7% | +$7.45K | ﹤0.01% | 1920 |
|
|
2016
Q2 | $850K | Buy |
41,962
+22,109
| +111% | +$402K | ﹤0.01% | 2142 |
|
|
2016
Q1 | $358K | Buy |
19,853
+2,482
| +14% | +$43.1K | ﹤0.01% | 2603 |
|
|
2015
Q4 | $458K | Buy |
17,371
+362
| +2% | +$8.15K | ﹤0.01% | 2478 |
|
|
2015
Q3 | $363K | Sell |
17,009
-100
| -0.6% | -$2.77K | ﹤0.01% | 2638 |
|
|
2015
Q2 | $453K | Buy |
+17,109
| New | +$489K | ﹤0.01% | 2629 |
|
Other funds holding BPMC
IA
HNB
California State Teachers Retirement System (CalSTRS)'s BPMC Position: Q3 2025 in Review
California State Teachers Retirement System (CalSTRS) sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 63,898 shares — an estimated $8.19M sold.
California State Teachers Retirement System (CalSTRS) first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $9.98M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- California State Teachers Retirement System (CalSTRS) reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 63,898 Blueprint Medicines shares in Q3 2025, an estimated $8.19M.
- California State Teachers Retirement System (CalSTRS) first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
- California State Teachers Retirement System (CalSTRS)'s Blueprint Medicines position peaked at $9.98M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q3 2025, filed 14 Nov 2025.